P3 Health Partners closed at $3.82 on Nov 5, down 6.83%, 76.8% below its 52-week closing high. Volume of 6.5K shares was 0.38× its 20-day average (below normal).
Split-adjusted performance: -32.1% over one month, +6.7% over six months, -54.8% over one year.
In the quarter ended Jun 30, 2026, revenue was $386.38M, up 8.6% from a year earlier, with a net margin of -0.6%.
Short interest was 11.3K shares at the Oct 15 settlement, down 17.0% from the prior report (0.8% of float, 1.0 days to cover).